The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study-Reference-Cited by-同舟云学术

The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study

Published:2016-03-11 Issue:9 Volume:122 Page:1408-1416
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Nakamura Tomoki¹,Matsumine Akihiko¹,Kawai Akira²,Araki Nobuhito³,Goto Takahiro⁴,Yonemoto Tsukasa⁵,Sugiura Hideshi⁶⁷,Nishida Yoshihiro⁸,Hiraga Hiroaki⁹,Honoki Kanya¹⁰,Yasuda Taketoshi¹¹,Boku Shogen¹²,Sudo Akihiro¹,Ueda Takafumi¹³

Affiliation:

1. Department of Orthopedic SurgeryMie University Graduate School of MedicineTsu Japan

2. Division of Orthopedic SurgeryNational Cancer Center HospitalTokyo Japan

3. Department of Orthopedic SurgeryOsaka General Medical CenterOsaka Japan

4. Department of Orthopedic Surgery and Musculoskeletal OncologyTokyo Metropolitan Cancer and Infectious Diseases Center Komagome HospitalTokyo Japan

5. Division of Orthopedic SurgeryChiba Cancer CenterChiba Japan

6. Department of Orthopedic SurgeryAichi Cancer CenterNagoya Japan

7. Department of Physical TherapyNagoya University Graduate School of MedicineNagoya Japan

8. Department of Orthopedic SurgeryNagoya University Graduate School of MedicineNagoya Japan

9. Department of Orthopedic SurgeryHokkaido Cancer CenterHokkaido Japan

10. Department of Orthopedic SurgeryNara Medical UniversityNara Japan

11. Department of Orthopedic SurgeryUniversity of ToyamaToyama Japan